Pharmafile Logo

Kath Kerry

ABPI London offices

ABPI bid to overturn NICE’s budget impact rules fails

One in five new medicines would have been affected by the rejected policy

- PMLiVE

Amgen pledges $1.5bn for CytomX preclinical cancer drugs

Stellar valuations for immuno-oncology candidates continue

Can Cinderella save us?

Motif Bio preps US filing after antibiotic clears phase III

The UK biopharma hopes to launch iclaprim by early 2019

- PMLiVE

Bicycle Therapeutics appoints former Pfizer VP Maria Koehler

She joins the UK biotech as its chief medical officer

- PMLiVE

Adelphi Research UK strengthens its offerings

Healthcare insight group welcomes six new starters

- PMLiVE

Effective strategic planning

The advantages of being nimble when responding to challenges

- PMLiVE

J&J seeks US OK to add CV claim to Invokana label

If approved the treatment could better compete with rivals Jardiance and Victoza

UK flag

Universal flu vaccine heads for UK trials

New vaccine targets core proteins of the virus

- PMLiVE

Hard Brexit could cost UK healthcare sector £2bn per year

Pharma and medical supply firms may face 10% revenue drop

- PMLiVE

Egg launches wearable patient insight experience ‘Virtual Mile’

The Virtual Mile glasses will pair with an app and make audio and visual recordings

- PMLiVE

Belgium’s TiGenix appoints Dr Gregory Gordon

He takes up a role as head of its US medical development

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links